» Authors » Keigo Fukase

Keigo Fukase

Explore the profile of Keigo Fukase including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 128
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nomura Y, Shun M, Kawashima M, Fujisue J, Fujimoto M, Miyahara S, et al.
Vasc Endovascular Surg . 2021 Jun; 55(8):882-884. PMID: 34105418
Venous aneurysms (VA), particularly superficial femoral VAs (SFVAs), are rare vascular lesions. A 65-year-old woman with a history of pulmonary embolism (PE), treated with tissue plasminogen activator and oral anticoagulation,...
2.
Matsumori M, Kawashima M, Aihara T, Fujisue J, Fujimoto M, Fukase K, et al.
Gen Thorac Cardiovasc Surg . 2020 Sep; 69(3):458-465. PMID: 32951140
Objective: Atrial functional mitral regurgitation (AFMR) is caused by atrial fibrillation and left atrial enlargement. Our study aimed to evaluate the efficacy of left atrial plication (LAP) for AFMR. Methods:...
3.
Anyanwu A, Kanthi Y, Fukase K, Liao H, Mimura T, Desch K, et al.
Arterioscler Thromb Vasc Biol . 2019 Mar; 39(4):e118-e129. PMID: 30816804
Objective- Leukocyte flux contributes to thrombus formation in deep veins under pathological conditions, but mechanisms that inhibit venous thrombosis are incompletely understood. Ectonucleotide di(tri)phosphohydrolase 1 ( ENTPD1 or Cd39), an...
4.
Sutton N, Hayasaki T, Hyman M, Anyanwu A, Liao H, Petrovic-Djergovic D, et al.
JCI Insight . 2017 Jan; 2(1):e89504. PMID: 28097233
Mechanical complications of myocardial infarction (MI) are often fatal. Little is known about endogenous factors that predispose to myocardial rupture after MI. Ectonucleoside triphosphate diphosphohydrolase (CD39) could be a critical...
5.
Okita Y, Yamanaka K, Okada K, Matsumori M, Inoue T, Fukase K, et al.
Eur J Cardiothorac Surg . 2014 Mar; 46(5):894-900. PMID: 24618390
Objectives: Presenting a surgical strategy for aorto-oesophageal fistula (AEF). Methods: From October 1999 to August 2013, 16 patients with AEF were treated at Kobe University Hospital. The mean age was...
6.
Liao H, Hyman M, Baek A, Fukase K, Pinsky D
J Biol Chem . 2010 Feb; 285(19):14791-805. PMID: 20178980
CD39 is a transmembrane enzyme that inhibits platelet reactivity and inflammation by phosphohydrolyzing ATP and ADP to AMP. Cyclic AMP (cAMP), an essential second messenger, is particularly important in regulating...
7.
Fukase K, Mukohara N, Yoshida M, Ozaki N, Shida T
Gen Thorac Cardiovasc Surg . 2007 Aug; 55(7):290-2. PMID: 17679258
We used the common hepatic artery (CHA) as an inflow site for a saphenous vein graft bypass to the right coronary system during off-pump coronary artery bypass grafting. The CHA...